GlaxoSmithKline's consumer health business will be named Haleon following its planned spinoff and listing on the London Stock Exchange later this year, according to the drugmaker. The name of the ...

He said that the growth prospects for consumer products are poor because ... or pay too much for a consumer health acquisition. Earlier this week it emerged that GSK's new head of pharma ...

Painkiller brands Panadol and Anadin will be bought under one roof under a giant deal between drug firms GlaxoSmithKline and Pfizer. The firms are combining their consumer healthcare businesses ...

In a report released on January 9, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

as well new oral care products that address a range of people’s needs, including prevention of early periodontal disease (gingivitis) and reduction in tooth sensitivity. GSK Consumer Healthcare ...

GlaxoSmithKline ... The global healthcare company, which has its headquarters in London, has already been preparing to separate its consumer goods division from its pharmaceutical business in ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

GSK has drawn on a vast bank of images and conversations from key global markets to help it establish a series of evolving “Health & Wellness Codes”. As GSK prepares to separate its pharma and ...

Given the strong valuations of consumer healthcare companies ... challenges to the firms' leading products. Our Uncertainty Rating for GSK is not materially affected by environmental, social ...

GSK plc announced an update regarding its total voting rights and capital for shareholders, as required by the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. As of December ...

GlaxoSmithKline will combine its consumer health business with Pfizer - split at 68% to 32% in equity holdings respectively - and its shares rose as much as 7.4% on the announcement. GSK is ...